BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21242079)

  • 1. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
    Mravčík V; Skařupová K; Orlíková B; Zábranský T; Karachaliou K; Schulte B
    Int J Drug Policy; 2011 Mar; 22(2):172-3. PubMed ID: 21242079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 7. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will.
    Worth H; Rawstorne P
    Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems.
    Lim MS; Cogger S; Quinn B; Hellard ME; Dietze PM
    Aust N Z J Public Health; 2015 Apr; 39(2):194-5. PubMed ID: 25559677
    [No Abstract]   [Full Text] [Related]  

  • 13. Methamphetamine and the expanding complications of amphetamines.
    Albertson TE; Derlet RW; Van Hoozen BE
    West J Med; 1999 Apr; 170(4):214-9. PubMed ID: 10344175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study.
    Noroozi A; Malekinejad M; Rahimi-Movaghar A
    J Psychoactive Drugs; 2018; 50(3):214-223. PubMed ID: 29377788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
    Stock AK; Beste C
    Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
    [No Abstract]   [Full Text] [Related]  

  • 19. The Psychostimulant Check-Up: A pilot study of a brief intervention to reduce illicit stimulant use.
    Smout MF; Longo M; Harrison S; Minniti R; Cahill S; Wickes W; White JM
    Drug Alcohol Rev; 2010 Mar; 29(2):169-76. PubMed ID: 20447225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.